FANCC and Friedreich ataxia: Osborn et al. used CRISPR/Cas9 to correct a c.456 +4 A > T mutation in the FA core complex gene FANCC, but were successful only after simultaneously complementing the FA defect and including a puromycin cassette to select for templated HDR events32.